Publications by authors named "Lisa Grace"

Claim this Profile
D
Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines.
Micael Lopez-Acevedo, Lisa Grace, Deanna Teoh, Regina Whitaker, David J Adams

Gynecol Oncol Res Pract· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.
Brittany Anne Davidson, Jennifer M Rubatt, David L Corcoran, Deanna K Teoh, Marcus Q Bernardini, Lisa A Grace

Front Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression.
Angeles Alvarez Secord, Deanna Teoh, Jingquan Jia, Andrew B Nixon, Lisa Grace

Int J Gynecol Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 Status is Associated with Thrombospondin1 Expression In vitro.
Angeles Alvarez Secord, Marcus Q Bernardini, Gloria Broadwater, Lisa A Grace, Zhiqing Huang

Front Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commercial sexual exploitation of children and the school nurse.
Lisa Goldblatt Grace, Maureen Starck, Jane Potenza, Patricia A Kenney, Anne H Sheetz

J Sch Nurs· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells.
Deanna Teoh, Tina A Ayeni, Jennifer M Rubatt, David J Adams, Lisa Grace

Gynecol Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.
Elizabeth L Jewell, Kathleen M Darcy, Alan Hutson, Paula S Lee, Laura J Havrilesky, Lisa A Grace

Gynecol Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Jennifer M Rubatt, Kathleen M Darcy, Alan Hutson, Sarah M Bean, Laura J Havrilesky, Lisa A Grace

Gynecol Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
Angeles Alvarez Secord, Kathleen M Darcy, Alan Hutson, Paula S Lee, Laura J Havrilesky, Lisa A Grace

Gynecol Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
Monique A Spillman, Judith Lacy, Susan K Murphy, Regina S Whitaker, Lisa Grace

Gynecol Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.

Gynecol Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis